BrightView
BrightView Health operates 70+ outpatient addiction treatment centers across five U.S. states, delivering medication-assisted treatment, behavioral health therapy, and social support services to over 20,000 patients annually with same-day access and broad insurance acceptance.
- Company typePublic
- Founded2015
- HeadquartersCincinnati, United States
- Headcount501–1,000
- GTM typeB2C
- OfferingServices
What BrightView does
BrightView Health is a Cincinnati, Ohio-based outpatient addiction treatment provider founded in 2015 that operates more than 70 treatment centers across five U.S. states (Ohio, Kentucky, Virginia, Maryland, and North Carolina) and serves over 20,000 patients in active care with a team of approximately 1,200 clinicians, counselors, and support staff. The company's core offering is an integrated outpatient treatment platform that combines medication-assisted treatment (MAT) using FDA-approved medications such as buprenorphine products (Suboxone, Sublocade), methadone, naltrexone (Vivitrol), acamprosate (Campral), and disulfiram (Antabuse) with evidence-based behavioral therapies including cognitive behavioral therapy and motivational interviewing, alongside case management and social support services addressing housing, employment, and legal needs.
Its core technology and operating model emphasize same-day/next-day treatment access — most patients begin medication and counseling within four hours of first contact — and a modular product suite that includes a gold-standard Opioid Treatment Program (OTP) with on-site medication dispensing, a dedicated Behavioral Health Therapy line, LGBTQIA+-affirming care, and telehealth at select locations. The company holds the Joint Commission Gold Seal of Approval and is Great Place to Work Certified, with integrated multidisciplinary care teams and dedicated executive leadership across Compliance, Regulatory Affairs, Quality Operations, and Revenue Cycle Management.
BrightView generates revenue primarily by billing Medicaid, Medicare, and commercial insurance plans for outpatient MAT, counseling, and case management, supplemented by a monthly self-pay option for uninsured patients. Its go-to-market is dual-track: direct-to-consumer acquisition via a 24/7 phone line, online scheduling, and walk-in availability, alongside a referral channel drawing from primary care, hospitals, emergency departments, behavioral health professionals, and justice system partners. The company has executed a programmatic expansion strategy through acquisitions of Column Health (August 2022) and Corebella Health & Wellness (February 2023), and signals continued scaling through dedicated VP-level Growth, Development, and Transformation roles.
BrightView firmographics
Firmographics- Name
- BrightView
- Legal name
- BrightView, LLC
- Website
- https://brightviewhealth.com
- Company type
- Public
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- BrightView Health operates 70+ outpatient addiction treatment centers across five U.S. states, delivering medication-assisted treatment, behavioral health therapy, and social support services to over 20,000 patients annually with same-day access and broad insurance acceptance.
- Ownership category
- akta.pro rank
BrightView industry classification
Industry- Product category
- Outpatient Addiction Treatment
- NAICS
- Outpatient Mental Health and Substance Abuse Centers (621420), Outpatient Mental Health and Substance Abuse Centers (62142)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)
- akta.pro primary industry
- Outpatient Substance Use Disorder (SUD) Treatment Programs (HLAFABAD)
- akta.pro secondary industry
- Medication-Assisted Treatment (MAT) & Opioid Treatment Programs (OTPs) (HLAFACAG)
Keywords
Where BrightView is headquartered
LocationHeadquarters
- HQ city
- Cincinnati
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
BrightView business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D, Others
Revenue model
- Insurance Billing: Revenue from billing Medicaid, Medicare, and commercial insurance plans for outpatient addiction treatment services including MAT, counseling, and case management.
- Self-Pay/Out-of-Pocket: Monthly self-pay option for patients without insurance coverage, with payment plans available.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Insurance-covered treatment |
| Subscription | Monthly | Self-pay treatment |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels7 records
BrightView product offering
Product offeringCore offering
BrightView Health provides outpatient addiction treatment combining FDA-approved Medication-Assisted Treatment (MAT) with individual and group counseling, behavioral therapies, and social support services. Patients are treated for alcohol, opioid, fentanyl, heroin, stimulant, depressant, and marijuana use disorders through personalized care plans delivered at 70+ centers across five states (Ohio, Kentucky, Virginia, Maryland, North Carolina), with same-day access typically within four hours of first contact.
Product overview
BrightView offers an integrated outpatient addiction treatment platform combining Medication-Assisted Treatment (MAT), individual and group counseling, and social support services. The core Outpatient Treatment Program serves as the main delivery model, with specialized modules including the Opioid Treatment Program (OTP), Behavioral Health Therapy, and LGBTQIA+-affirming care. Treatment is personalized and may include FDA-approved medications such as buprenorphine products (Suboxone, Sublocade), methadone, naltrexone (Vivitrol), acamprosate (Campral), and disulfiram (Antabuse). Telehealth Services provide virtual access at select locations. The company operates 70+ treatment centers across five states with over 1,200 team members supporting 20,000+ patients in active care.
Differentiator
Problem solved
Functional benefit
Products and services
- Outpatient Addiction Treatment Program
Quantifiable outcome
- 44% decrease in illicit substance use after 90 days of treatment
- +3 more outcomes
Companies that use BrightView
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles2 records
BrightView technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
BrightView partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- The VillagescoreBrightView expanded its partnership with The Villages to manage golf courses. The partnership extension demonstrates BrightView's capabilities in golf course management services.
- Column HealthcoreColumn Health, which operated addiction treatment clinics in Massachusetts, was acquired by BrightView Health in August 2022. This acquisition expanded BrightView's geographic footprint into Massachusetts and brought Column Health's evidence-based addiction treatment model into the BrightView network.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
BrightView competitors and assessment
Company assessmentDirect peers
- BayMark Health Services: Largest US provider of office-based opioid treatment and methadone maintenance, operating a multi-state network of OTPs and MAT clinics. Most directly comparable to BrightView in service mix (MAT, OTP, counseling) and multi-state outpatient delivery model.
- CleanSlate Outpatient Addiction Medicine: Multi-state outpatient MAT provider focused on office-based buprenorphine treatment for opioid and alcohol use disorder. Directly comparable outpatient model, payer mix, and target patient population.
- American Addiction Centers: Public addiction-treatment operator offering inpatient, residential, and outpatient services across multiple states. Comparable patient population and integrated MAT + therapy model, with broader acuity mix.
- Pegasus Health: Multi-state outpatient MAT provider offering buprenorphine-based treatment and counseling services. Directly comparable office-based opioid treatment model and target patient population.
Broad incumbents
- Acadia Healthcare: Public behavioral-health operator with inpatient psychiatric and residential treatment facilities as well as expanding outpatient services. Overlaps in SUD treatment delivery and referral networks at greater scale.
- Hazelden Betty Ford Foundation: Established nonprofit addiction treatment provider with residential programs and outpatient services. Overlaps in evidence-based MAT, behavioral therapy, and multi-state clinical footprint.
- Caron Treatment Centers: Nonprofit addiction treatment provider with residential, outpatient, and MAT services across multiple states. Comparable whole-person care model with overlapping patient populations in the Eastern US.
Regional players
- Pyramid Healthcare: Regional addiction and behavioral-health provider in the Mid-Atlantic and Northeast offering MAT, residential, and outpatient programs. Comparable integrated SUD model with regional overlap to BrightView's footprint.
Emerging players
- Eleanor Health: Value-based outpatient addiction and mental-health provider with a multi-state clinic footprint and significant payer partnerships. Comparable outpatient MAT-plus-therapy model targeting Medicaid and commercial populations.
- Addiction Campuses: Multi-state addiction treatment operator offering residential, partial hospitalization, and outpatient services including MAT. Overlaps in integrated SUD care model across multiple state geographies.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
BrightView social profiles
Digital presenceBrightView financial estimates
Financial estimateRevenue estimate
Valuation estimate
BrightView leadership team
Management profileNumber of profiles
Profiles8 records
BrightView funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BrightView M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BrightView
What does BrightView do?
BrightView Health provides outpatient addiction treatment combining FDA-approved Medication-Assisted Treatment (MAT) with individual and group counseling, behavioral therapies, and social support services. Patients are treated for alcohol, opioid, fentanyl, heroin, stimulant, depressant, and marijuana use disorders through personalized care plans delivered at 70+ centers across five states (Ohio, Kentucky, Virginia, Maryland, North Carolina), with same-day access typically within four hours of first contact.
Is BrightView a public or private company?
BrightView is a public company. It is classified as unknown and is currently operating.
When was BrightView founded?
BrightView was founded in 2015. It employs 501 to 1,000 people.
Where is BrightView based?
BrightView is headquartered in Cincinnati, United States, in the North America region.
How does BrightView make money?
Two revenue lines are on record. Insurance Billing is the primary driver. The others are self-Pay/Out-of-Pocket.
Who are BrightView's main competitors?
Direct peers on record are BayMark Health Services, CleanSlate Outpatient Addiction Medicine, American Addiction Centers and Pegasus Health. Broad incumbents are Acadia Healthcare, Hazelden Betty Ford Foundation and Caron Treatment Centers. Pyramid Healthcare is listed as a regional player. Emerging players are Eleanor Health and Addiction Campuses.
Does BrightView have an API?
No public API is recorded for BrightView.
What industry is BrightView in?
BrightView's product category is Outpatient Addiction Treatment. Its primary akta.pro industry code is HLAFABAD, Outpatient Substance Use Disorder (SUD) Treatment Programs, with a secondary code of HLAFACAG, Medication-Assisted Treatment (MAT) & Opioid Treatment Programs (OTPs). Its NAICS code is 621420 and its SIC code is 8093.